Lowell Sears

Directeur Général chez Sears Capital Management, Inc.

Profil

Mr. Lowell E.
Sears is Chairman at Cellerant Therapeutics, Inc. and Founder, Chairman & Chief Executive Officer at Sears Capital Management, Inc. He is on the Board of Directors at SymBio Pharmaceuticals Ltd and Chief Investment Officer at Sears Capital Management, Inc. Prior to founding Sears Capital Management, Inc. in April 1994, Mr. Sears was employed as a Principal by Peninsula Pharmaceuticals, Inc., Chairman by Elitra Pharmaceuticals, Inc., Chief Financial Officer by Amgen, Inc., and Chief Financial Officer by Atlantic Richfield Co. He also served on the board at Asthmatx, Inc., Novacea, Inc., Novalar Pharmaceuticals, Inc., Coapt Systems, Inc., Dendreon Corp., CoCensys, Inc., Neose Technologies, Inc., Techne Corp., Corthera, Inc., and InteKrin Therapeutics, Inc. Mr. Sears received his degree in Economics from Claremont McKenna College and his MBA from Stanford University.

Postes actifs de Lowell Sears

Sociétés	Poste	Début
Sears Capital Management, Inc.	Directeur Général	01/04/1994
Halcyon Medical Centre	Directeur/Membre du Conseil	01/04/2014

Anciens postes connus de Lowell Sears

Sociétés	Poste	Fin
Vital Therapies, Inc.	Directeur/Membre du Conseil	12/04/2019
SiteOne Therapeutics, Inc.	Président	01/03/2017
SYMBIO PHARMACEUTICALS LIMITED	Directeur/Membre du Conseil	01/03/2017
Cellerant Therapeutics, Inc.	Président	01/01/2017
Novalar Pharmaceuticals, Inc.	Directeur/Membre du Conseil	18/05/2011